SynthesisThe oncologist2017

Safety and Tolerability of PD-1/PD-L1 Inhibitors Compared with Chemotherapy in Patients with Advanced Cancer: A Meta-Analysis.

Tomohiro F Nishijima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.